Biolase (BIOL) Reports Q4 Loss of $0.07
Tweet
Share
E-mailGet Alerts BIOL Hot Sheet
Join SI Premium – FREE
Biolase (NASDAQ: BIOL) reported Q4 EPS of ($0.07). Revenue for the quarter came in at $13.76 million versus the consensus estimate of $13.23 million.
For earnings history and earnings-related data on Biolase (BIOL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TJX stock drops as profit outlook falls short of analyst estimates
- Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
- Keysight Technologies (KEYS) Tops Q3 EPS by 59c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
